Telehealth-delivered opioid agonist therapy for the treatment of adults with opioid use disorder review of clinical effectiveness, cost-effectiveness, and guidelines
This Rapid Response report aims to review the effectiveness of the use of telehealth-delivered opioid agonist therapy (OAT) compared to standard OAT. Cost-effectiveness and evidence-based guidelines regarding the use of telehealth-delivered OAT for the treatment of opioid use disorders will also be...
Main Authors: | , |
---|---|
Corporate Author: | |
Format: | eBook |
Language: | English |
Published: |
Ottawa
CADTH
October 5, 2018, 2018
|
Edition: | Version 1.0 |
Series: | CADTH rapid response report: summary with critical appraisal
|
Online Access: | |
Collection: | National Center for Biotechnology Information - Collection details see MPG.ReNa |
Summary: | This Rapid Response report aims to review the effectiveness of the use of telehealth-delivered opioid agonist therapy (OAT) compared to standard OAT. Cost-effectiveness and evidence-based guidelines regarding the use of telehealth-delivered OAT for the treatment of opioid use disorders will also be examined |
---|---|
Physical Description: | 1 PDF file (13 pages) illustrations |